Beijing Science Sun Pharmaceutical Co Ltd (300485) — Cash Flow Quality Index
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Cash Flow Quality Index of 7.04x as of September 2025. Operating cash flow of CN¥28.68 Million exceeds net income of CN¥4.07 Million, indicating high earnings quality where cash backs reported profits. Explore 300485 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Science Sun Pharmaceutical Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for Beijing Science Sun Pharmaceutical Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 300485 cash flow metrics.
Annual Cash Flow Quality Index for Beijing Science Sun Pharmaceutical Co Ltd (2012–2023)
Year-by-year earnings quality comparison for Beijing Science Sun Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.21x | CN¥21.21 Million | CN¥102.92 Million | ▼ -62.2% |
| 2022 | 0.54x | CN¥110.43 Million | CN¥202.65 Million | ▲ +19.6% |
| 2021 | 0.46x | CN¥183.30 Million | CN¥402.27 Million | ▼ -73.9% |
| 2020 | 1.74x | CN¥263.73 Million | CN¥151.28 Million | ▲ +49.1% |
| 2019 | 1.17x | CN¥172.52 Million | CN¥147.55 Million | ▲ +126.0% |
| 2018 | 0.52x | CN¥146.52 Million | CN¥283.16 Million | ▲ +34.6% |
| 2017 | 0.38x | CN¥108.21 Million | CN¥281.53 Million | ▼ -53.4% |
| 2016 | 0.82x | CN¥212.89 Million | CN¥258.35 Million | ▲ +1.8% |
| 2015 | 0.81x | CN¥169.36 Million | CN¥209.23 Million | ▼ -23.5% |
| 2014 | 1.06x | CN¥214.23 Million | CN¥202.43 Million | ▼ -13.6% |
| 2013 | 1.22x | CN¥196.82 Million | CN¥160.75 Million | ▲ +6.8% |
| 2012 | 1.15x | CN¥151.93 Million | CN¥132.58 Million | — |